Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassem Sadek

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Behavioural Pharmacology|April 30, 2014
Anticonvulsive effect of nonimidazole histamine H3 receptor antagonistsBassem Sadek, Kamil Kuder, Dhanasekaran Subramanian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 27, 2021
The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actionsKarthikkumar Venkatachalam, Nermin Eissa, Mohamed Al Awad, et al.
Nutrients|October 1, 2020
Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated ComplicationsHebaallah Mamdouh Hashiesh, Mohamed F Nagoor Meeran, Charu Sharma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 6, 2021
A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoidHebaallah Mamdouh Hashiesh, Charu Sharma, Sameer N Goyal, et al.
Drug Design, Development and Therapy|September 17, 2013
Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E2 inhibitory propertiesCarmen Limban, Alexandru Vasile Missir, Khairi Mustafa Salem Fahelelbom, et al.
International Journal of Molecular Sciences|January 8, 2023
Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in MiceNermin Eissa, Mohamed Al Awad, Shilu Deepa Thomas, et al.
International Journal of Molecular Sciences|August 26, 2023
The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in MiceSabna Abdalla, Nermin Eissa, Petrilla Jayaprakash, et al.
Pharmacological Research|June 8, 2012
N3,N7-diaminophenothiazinium derivatives as antagonists of α7-nicotinic acetylcholine receptors expressed in Xenopus oocytesBassem Sadek, Abrar Ashoor, Abdula Al Mansouri, et al.
European Journal of Pharmacology|March 9, 2025
Mitigating effects of H3 receptor antagonism on cerebellar autophagic pathways and behavioral phenotypes in BTBR T+ tf/J mouse model of autism spectrum disorderNermin Eissa, Petrilla Jayaprakash, Shouq Aljneibi, et al.
International Journal of Molecular Sciences|March 6, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in MiceNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Behavioural Pharmacology|April 30, 2014
Anticonvulsive effect of nonimidazole histamine H3 receptor antagonistsBassem Sadek, Kamil Kuder, Dhanasekaran Subramanian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 27, 2021
The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actionsKarthikkumar Venkatachalam, Nermin Eissa, Mohamed Al Awad, et al.
Nutrients|October 1, 2020
Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated ComplicationsHebaallah Mamdouh Hashiesh, Mohamed F Nagoor Meeran, Charu Sharma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 6, 2021
A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoidHebaallah Mamdouh Hashiesh, Charu Sharma, Sameer N Goyal, et al.
Drug Design, Development and Therapy|September 17, 2013
Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E2 inhibitory propertiesCarmen Limban, Alexandru Vasile Missir, Khairi Mustafa Salem Fahelelbom, et al.
International Journal of Molecular Sciences|January 8, 2023
Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in MiceNermin Eissa, Mohamed Al Awad, Shilu Deepa Thomas, et al.
International Journal of Molecular Sciences|August 26, 2023
The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in MiceSabna Abdalla, Nermin Eissa, Petrilla Jayaprakash, et al.
Pharmacological Research|June 8, 2012
N3,N7-diaminophenothiazinium derivatives as antagonists of α7-nicotinic acetylcholine receptors expressed in Xenopus oocytesBassem Sadek, Abrar Ashoor, Abdula Al Mansouri, et al.
European Journal of Pharmacology|March 9, 2025
Mitigating effects of H3 receptor antagonism on cerebellar autophagic pathways and behavioral phenotypes in BTBR T+ tf/J mouse model of autism spectrum disorderNermin Eissa, Petrilla Jayaprakash, Shouq Aljneibi, et al.
International Journal of Molecular Sciences|March 6, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in MiceNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Pageof 10